Difficulty: Medium
Average Score: 85%
Practice
A healthy 20-day-old male examination reveals a palpable liver margin below the right costal margin; lab findings: white blood count, 18700/mm3; hemoglobin, 8.8 g/dl; blast cells, 10%; the BEST approach for the management is consistent with acute myeloproliferative disorder
Correct answer
A
Rationale
The correct answer is A) intensive chemotherapy. In this scenario, the presence of blast cells in the peripheral blood of a 20-day-old infant with hepatomegaly and abnormal blood counts suggests a high likelihood of acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL), both of which require intensive chemotherapy for treatment.
Option B) low dose chemotherapy pulses would not be the best approach as aggressive treatment is usually required for acute myeloproliferative disorders to achieve remission and prevent disease progression.
Option C) bone marrow transplantation is typically reserved for cases of refractory or relapsed disease, not as initial management.
Option D) close follow-up alone is insufficient as immediate treatment is necessary in the presence of blast cells and abnormal blood counts in a pediatric patient.
From an educational standpoint, it is crucial for healthcare providers to recognize the urgency of appropriate management in pediatric patients presenting with concerning findings like blast cells in the blood. Understanding the treatment approaches for pediatric leukemias is essential for providing timely and effective care to these vulnerable patients.
Option B) low dose chemotherapy pulses would not be the best approach as aggressive treatment is usually required for acute myeloproliferative disorders to achieve remission and prevent disease progression.
Option C) bone marrow transplantation is typically reserved for cases of refractory or relapsed disease, not as initial management.
Option D) close follow-up alone is insufficient as immediate treatment is necessary in the presence of blast cells and abnormal blood counts in a pediatric patient.
From an educational standpoint, it is crucial for healthcare providers to recognize the urgency of appropriate management in pediatric patients presenting with concerning findings like blast cells in the blood. Understanding the treatment approaches for pediatric leukemias is essential for providing timely and effective care to these vulnerable patients.